Acumen Pharmaceuticals Inc (ABOS) USD0.0001

Sell:$3.17Buy:$3.69$0.10 (3.15%)

NASDAQ:0.09%
Market closed | Prices delayed by at least 15 minutes
Sell:$3.17
Buy:$3.69
Change:$0.10 (3.15%)
Market closed | Prices delayed by at least 15 minutes
Sell:$3.17
Buy:$3.69
Change:$0.10 (3.15%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
19 January 2024
Daniel Joseph O'ConnellPresident/CEO
Sell
Option/Award related
15,200$3.47$52,753.12502,485
19 January 2024
Derek M MeisnerChief Legal/Compliance Officer
Sell
Option/Award related
8,933$3.48$31,048.43108,867
18 January 2024
W. Matthew (Matt) ZugaCFO
Sell
Tax related
4,242$3.71$15,716.61211,445
18 January 2024
Eric SiemersOther Level A
Sell
Tax related
3,124$3.71$11,603.79117,576
18 January 2024
Russell BartonCOO
Sell
Tax related
2,833$3.73$10,555.1996,867

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining

There was a problem loading director deals data. You can refresh the page to try again.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.